Newsfeeds - Spark Newswire

1 minute read

After Elon Musk’s Twitter Blue Chaos, Platform Now ‘Rolling Out’ New Feature To Enable Companies Authenticate Users

November 14, 2:50 AM

Tesla Inc. (NASDAQ: TSLA) CEO and now Twitter chief Elon Musk has announced that the microblogging site will soon enable organizations to manage affiliated accounts.

LLY

3 minute read

Elon Musk’s Blue Check Verification Hurts: 8 Companies That Took A Hit From Twitter Account Impersonators

By Shanthi Rexaline

November 13, 6:14 PM

Elon Musk’s takeover of Twitter has only served to compound the social media platform’s woes, at least during the initial stage.

2 minute read

Twitter Blue Account Declares Eli Lilly Giving Away Free Insulin, Pharma Giant Says Its Fake

By Bibhu Pattnaik

November 12, 12:08 PM

A fake account with the handle @EliLillyandCo posted last week on Twitter that Eli Lilly And Co (NYSE: LLY) is giving away free insulin.

LLY

1 minute read

Goldman Sachs Maintains Neutral on Eli Lilly, Raises Price Target to $313

By Benzinga Newsdesk

November 8, 9:05 AM

Goldman Sachs analyst Chris Shibutani maintains Eli Lilly (NYSE:LLY) with a Neutral and raises the price target from $281 to $313.

LLY

3 minute read

Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch

By AJ Fabino

November 7, 2:06 PM

As voters endeavor to select the congressional candidates they believe would best assist the U.S. in navigating through historical issues it is currently facing, investors are wondering what's going to happen to equities.

ABBV

15 minute read

Lilly To Begin Rollout Of Tempo Personalized Diabetes Management Platform

By Benzinga Newsdesk

November 7, 12:32 PM

Centralized experience supports diabetes self-management through medication reminders, education resources and insulin dose logging Data shared through platform interface may help healthcare providers make

LLY

1 minute read

$1000 Invested In Eli Lilly 5 Years Ago Would Be Worth This Much Today

By Benzinga Insights

November 4, 1:13 PM

Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 26.17% on an annualized basis producing an average annual return of 33.67%. Currently, Eli Lilly has a market capitalization of $337.71 billion.

LLY